2009 annual financial data
Celldex Therapeutics 2009 Operating cash flow margin
Direct answer
Operating cash flow margin was -196.77%.
Operating income was -32,854,000 USD and net income was -36,525,000 USD.
Operating cash flow was -29,869,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,180,000 USD
- Operating income
- -32,854,000 USD
- Net income
- -36,525,000 USD
- Operating cash flow
- -29,869,000 USD